期刊文献+

慢性肾衰竭高磷血症研究及治疗进展 被引量:24

Recent progresses in clinical study and treatment of hyperphosphatemia in chronic renal failure
下载PDF
导出
摘要 在慢性肾衰竭时,机体磷代谢发生紊乱,伴随血磷升高出现继发性甲状旁腺功能亢进症(SHPT),维生素D代谢障碍,肾性骨病以及心血管系统钙化,严重地影响患者的生活质量。近年来,对高血磷作为一种独立的危险因素对机体的损害以及对与磷排泄有关的钠磷协同转运子作出的一定的研究,而非铝、非钙磷结合剂的使用,无疑又使高磷血症的治疗跨越了一大步。
作者 苗华 潘明明
出处 《中国血液净化》 2007年第9期500-502,共3页 Chinese Journal of Blood Purification
  • 相关文献

参考文献17

  • 1Almaden Y,Hernandez A.High phosphate level directly stimulates parathyroid tissue in vitro[J].J Am Soc Nephrol,1998,9:1845-1852.
  • 2Roussanne MC.Lieberherr M.Human parathyroid cell proliferation in response to calcium,NPS R-467,calcitriol and phosphate[J].Eur J Clin Invest,2001,31:610-616.
  • 3Francesco Locatelli,Jorge B.Management of disturbance of calcium and phosphate metabolism in chronic renal insufficiency,with emphasis on the control of hyperphosphataemia[J].Nephrol Dial Transplant,2002,17:723-731.
  • 4Foley RN,Parfrey PS,Sarnak MJ.Clinical epidemiology of cardiovascular disease in chronic renal disease[J].Am J Kidney Dis,1998,32:S112-S119.
  • 5Willian G.Goodman.Importance of hyperphosphataemia in the cardio-renal axis[J].Nephrol Dial Transplant,2004,19:14-i8 DOI:10.1093/ndt/gfh1001.
  • 6徐斌.透析患者钙磷代谢异常的新认识及治疗[J].肾脏病与透析肾移植杂志,2002,11(3):283-286. 被引量:14
  • 7黄雯.钙磷代谢及肾脏对钙磷平衡的调节[J].中国血液净化,2004,3(4):175-177. 被引量:18
  • 8Gongzalez EA.The role of cytokines in skeletal remodelling:possible consequences for renal osteodystrophy[J].Nephrol dial transplant,2000,(15):945-950.
  • 9Ken-Ichi Miyamoto,Mikiko Ito,Hiriko Segawa,et al.Molecular targets of hyperphosphataemia in chronic renal failure[J]Nephrol Dial Transplant,2003,18[Suppl 3][J]:iii79-iii80.
  • 10Murer H,Hernando N,Forster I,et al.Regulation of Na/Pitransporter in the proximal tubule[J].Annu Rev Physiol,2003,65:531-542.

二级参考文献30

  • 1林善琰主编.当代肾脏病学[M].上海: 上海科技教育出版社,2001,9.286-289,775-777.
  • 2[1]Block GA,Hulbert-Shearon TE,Levin NW et al.Association of serum phosphorus and calcium×phosphate product with mortality risk in chronic hemodialysis patients;a national study.Am J Kidney Dis,1998,31:607
  • 3[2]Levin NW,Hulbest-Shearon TE,Strawdesman RL et al.Which causes of death are related to hyperphatemia in hemodialysis patients?J Am Soc Nephrol,1998,9:217A
  • 4[3]Braun J,Oldendorf M,Moshage W et al.Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients.Am J Kidney Dis,1996,27:394
  • 5[4]Goodman WG,Goldin J,Kuizon BD et al.Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis.N Engl J Med,2000,342:1478
  • 6[5]Slatopolsky E,Brown A,Dusso A.Role of phosphorus in the pathogenesis of secondary hyperparathyroidism.Am J Kidney Dis,2001,37:(Suppl 2):S54
  • 7[6]Bleyer AJ,Burke S,Dillon M et al.A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients.Am J Kidney Dis,1999,33:694
  • 8[7]Chertow G,Burke S,Dillon M et al.Long-term effects of sevelamer hydrochloride on the calcium×phosphate product and lipid profile of haemodialysis patients.Nephrol Dial Transplant,1999,14:2907
  • 9[8]Raggi P,Burke S,Dillon M et al.Sevelamer attenuates the progression of coronary and aortic calcification compared with cacium-based phosphate binders [abstract].J Am Soc Nephrol,2001,12:A1232
  • 10[9]Burke S,Amin N,Incerti C et al.Sevelamer hydrochloride (Renagel),a nonabsorbed phosphate-binding polymer,does not interfere with digoxin or warfarin pharmacokinetisc.J Clin Pharmacol,2001,41:193

共引文献36

同被引文献219

引证文献24

二级引证文献133

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部